Subscribe to our press releases
ChromoGenics receives additional order from Vasakronan
Within less than a year, ChromoGenics has gain confidence by delivering window glasses to Vasakronan not less than three times. The latest project will also be installed in Uppsala, now at the property Kvarteret Duvan.
The property was designed by architect Dag Ribbling and built in 1962. It is centrally located and close to Uppsala’s pedestrian street and Central Station. Kvarteret Duvan which today mainly consists retail premises, will be rebuilt and replaced with office space. ChromoGenics is also helping out in the refurbishing of the window frames. This type of renovation requires high demands on the finished surfaces when it comes to indoor temperature and daylighting and window maintenance. The delivery comprises 19 windows glass with associated installation and control systems. The insulating capacity of the windows will also be drastically improved. The order value is over 300.000 SEK.
“It feels great that we again manage Vasakronan’s trust to deliver our window glass ConverLight Dynamic 75 that we are so proud of. It is undoubtedly a window with enormous potential and capacity,” says Jerker Lundgren CEO of ChromoGenics.
Jerker Lundgren, CEO
Lars Ericsson, CFO and Head of Communications
Tel: +46 (0)18 430 0430
Certified Adviser: G&W Fondkommission, e-mail: email@example.com, tel.: +46 (0) 8 503 000 50
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
ChromoGenics offers dynamic glass with controllable heat- and light transmission and static glass with world leading performance. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.
ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.